BACKGROUND: Sleep disruption and fatigue are ubiquitous among cancer patients and are sources of stress that may compromise treatment outcomes. Previously, we showed that a cognitive behavioral stress management (CBSM) intervention reduced anxiety and other stress-related processes in women undergoing primary treatment for breast cancer. PURPOSE: This study examined secondary outcomes from a CBSM intervention trial for women with early-stage breast cancer to test if CBSM would improve sleep quality and fatigue among these patients at a single site in southern Florida. CBSM-related effects have already been demonstrated for indicators of psychosocial adaptation (e.g., general and cancer-related anxiety). METHODS: Patients were randomized to CBSM (n= 120) or a 1-day psychoeducation control group (n= 120). The Pittsburgh Sleep Quality Index (PSQI) and Fatigue Symptom Inventory were completed prior to randomization and 6 and 12 months after the baseline assignment. RESULTS: In latent growth analyses, women in CBSM reported greater improvements in PSQI sleep quality scores than controls, although there were no significant differences between conditions on PSQI total scores. Women in CBSM also reported greater reductions in fatigue-related daytime interference than controls, though there were no significant differences in changes in fatigue intensity. Changes in sleep quality were associated with changes in fatigue. CONCLUSIONS: Future work may consider integrating sleep and fatigue content into stress management interventions for women with early-stage breast cancer.
RCT Entities:
BACKGROUND:Sleep disruption and fatigue are ubiquitous among cancerpatients and are sources of stress that may compromise treatment outcomes. Previously, we showed that a cognitive behavioral stress management (CBSM) intervention reduced anxiety and other stress-related processes in women undergoing primary treatment for breast cancer. PURPOSE: This study examined secondary outcomes from a CBSM intervention trial for women with early-stage breast cancer to test if CBSM would improve sleep quality and fatigue among these patients at a single site in southern Florida. CBSM-related effects have already been demonstrated for indicators of psychosocial adaptation (e.g., general and cancer-related anxiety). METHODS:Patients were randomized to CBSM (n= 120) or a 1-day psychoeducation control group (n= 120). The Pittsburgh Sleep Quality Index (PSQI) and Fatigue Symptom Inventory were completed prior to randomization and 6 and 12 months after the baseline assignment. RESULTS: In latent growth analyses, women in CBSM reported greater improvements in PSQI sleep quality scores than controls, although there were no significant differences between conditions on PSQI total scores. Women in CBSM also reported greater reductions in fatigue-related daytime interference than controls, though there were no significant differences in changes in fatigue intensity. Changes in sleep quality were associated with changes in fatigue. CONCLUSIONS: Future work may consider integrating sleep and fatigue content into stress management interventions for women with early-stage breast cancer.
Authors: Sonia Ancoli-Israel; Lianqi Liu; Matthew R Marler; Barbara A Parker; Vicky Jones; Georgia Robins Sadler; Joel Dimsdale; Mairav Cohen-Zion; Lavinia Fiorentino Journal: Support Care Cancer Date: 2005-07-12 Impact factor: 3.603
Authors: D M Hann; P B Jacobsen; L M Azzarello; S C Martin; S L Curran; K K Fields; H Greenberg; G Lyman Journal: Qual Life Res Date: 1998-05 Impact factor: 4.147
Authors: Jamie M Stagl; Suzanne C Lechner; Charles S Carver; Laura C Bouchard; Lisa M Gudenkauf; Devika R Jutagir; Alain Diaz; Qilu Yu; Bonnie B Blomberg; Gail Ironson; Stefan Glück; Michael H Antoni Journal: Breast Cancer Res Treat Date: 2015-10-30 Impact factor: 4.872
Authors: Ashley W-T Wang; Laura C Bouchard; Lisa M Gudenkauf; Devika R Jutagir; Hannah M Fisher; Jamie M Jacobs; Bonnie B Blomberg; Suzanne C Lechner; Charles S Carver; Michael H Antoni Journal: J Psychosom Res Date: 2018-07-23 Impact factor: 3.006
Authors: Donald J Fogelberg; Michael V Vitiello; Jeanne M Hoffman; Alyssa M Bamer; Dagmar Amtmann Journal: Arch Phys Med Rehabil Date: 2014-10-23 Impact factor: 3.966
Authors: Bronwyn A Morris; Frances P Thorndike; Lee M Ritterband; Nick Glozier; Jeff Dunn; Suzanne K Chambers Journal: Support Care Cancer Date: 2014-10-10 Impact factor: 3.603
Authors: Hannah M Fisher; Jamie M Jacobs; Chloe J Taub; Suzanne C Lechner; John E Lewis; Charles S Carver; Bonnie B Blomberg; Michael H Antoni Journal: Gen Hosp Psychiatry Date: 2017-05-29 Impact factor: 3.238
Authors: Sara F Milrad; Daniel L Hall; Devika R Jutagir; Emily G Lattie; Gail H Ironson; William Wohlgemuth; Maria Vera Nunez; Lina Garcia; Sara J Czaja; Dolores M Perdomo; Mary Ann Fletcher; Nancy Klimas; Michael H Antoni Journal: J Neuroimmunol Date: 2016-12-14 Impact factor: 3.478
Authors: Daniel L Hall; Michael H Antoni; Emily G Lattie; Devika R Jutagir; Sara J Czaja; Dolores Perdomo; Suzanne C Lechner; Jamie M Stagl; Laura C Bouchard; Lisa M Gudenkauf; Lara Traeger; MaryAnn Fletcher; Nancy G Klimas Journal: Fatigue Date: 2015
Authors: Michael H Antoni; Laura C Bouchard; Jamie M Jacobs; Suzanne C Lechner; Devika R Jutagir; Lisa M Gudenkauf; Charles S Carver; Susan Lutgendorf; Steven W Cole; Marc Lippman; Bonnie B Blomberg Journal: Psychoneuroendocrinology Date: 2016-09-24 Impact factor: 4.905
Authors: Cecile A Lengacher; Richard R Reich; Carly L Paterson; Heather S Jim; Sophia Ramesar; Carissa B Alinat; Pinky H Budhrani; Jerrica R Farias; Melissa M Shelton; Manolete S Moscoso; Jong Y Park; Kevin E Kip Journal: Psychooncology Date: 2014-06-18 Impact factor: 3.894